Publications in collaboration with researchers from Universidad de Málaga (58)

2024

  1. Correction: Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders(Translational Psychiatry, 10.1038/s41398-023-02523-1)

    Translational Psychiatry

  2. Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study

    Neuropsychobiology, Vol. 83, Núm. 2, pp. 73-88

2023

  1. Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  2. Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder

    International journal of molecular sciences, Vol. 24, Núm. 11

  3. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  4. Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  5. Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders

    Translational Psychiatry, Vol. 13, Núm. 1

2022

  1. An fMRI meta-analysis of the role of the striatum in everyday-life vs laboratory-developed habits

    Neuroscience and Biobehavioral Reviews, Vol. 141

  2. Galanin N-terminal fragment (1−15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic system

    Biomedicine and Pharmacotherapy, Vol. 153

  3. Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex

    Biomedicines, Vol. 10, Núm. 5

  4. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders

    Brain Sciences, Vol. 12, Núm. 5

  5. Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder

    Biomedicines, Vol. 10, Núm. 5

2021

  1. Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder

    Scientific Reports, Vol. 11, Núm. 1

  2. Inflammatory factors and depression in substance use disorder

    The Neuroscience of Depression: Genetics, Cell Biology, Neurology, Behavior, and Diet (Elsevier), pp. 149-160

  3. Inflammatory factors and depression in substance use disorder

    The Neuroscience of Depression, 1st Edition: Volume 1-2 (Elsevier), pp. V2-149-V2-160

  4. Influence of gender and education on cocaine users in an outpatient cohort in Spain

    Scientific Reports, Vol. 11, Núm. 1

  5. Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder

    Scientific Reports, Vol. 11, Núm. 1

  6. Plasma concentrations of lysophosphatidic acid and autotaxin in abstinent patients with alcohol use disorder and comorbid liver disease

    Biomedicines, Vol. 9, Núm. 9

  7. Sex-specific behavioral and neurogenic responses to cocaine in mice lacking and blocking dopamine D1 or dopamine D2 receptors

    Journal of Comparative Neurology, Vol. 529, Núm. 8, pp. 1724-1742

  8. Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brain

    Brain Structure and Function, Vol. 226, Núm. 7, pp. 2243-2264